Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcadia Biosciences (RKDA) Long-Term Investments (2016)

Historic Long-Term Investments for Arcadia Biosciences (RKDA) over the last 3 years, with Q4 2016 value amounting to $2.5 million.

  • Arcadia Biosciences' Long-Term Investments fell 8735.06% to $2.5 million in Q4 2016 from the same period last year, while for Dec 2016 it was $2.5 million, marking a year-over-year decrease of 8735.06%. This contributed to the annual value of $2.5 million for FY2016, which is 8735.06% down from last year.
  • As of Q4 2016, Arcadia Biosciences' Long-Term Investments stood at $2.5 million, which was down 8735.06% from $3.5 million recorded in Q3 2016.
  • In the past 5 years, Arcadia Biosciences' Long-Term Investments ranged from a high of $19.7 million in Q4 2015 and a low of $500000.0 during Q4 2014
  • Its 3-year average for Long-Term Investments is $5.5 million, with a median of $2.5 million in 2016.
  • Per our database at Business Quant, Arcadia Biosciences' Long-Term Investments soared by 384960.0% in 2015 and then crashed by 8735.06% in 2016.
  • Quarter analysis of 3 years shows Arcadia Biosciences' Long-Term Investments stood at $500000.0 in 2014, then soared by 3849.6% to $19.7 million in 2015, then tumbled by 87.35% to $2.5 million in 2016.
  • Its Long-Term Investments was $2.5 million in Q4 2016, compared to $3.5 million in Q3 2016 and $6.9 million in Q2 2016.